Human immunodeficiency virus-1 Tat activates NF-κB via physical interaction with IκB-α and p65.
about
Recent advances on viral manipulation of NF-κB signaling pathwayGene Expression Profiles of HIV/AIDS Patients with Qi-Yin Deficiency and Dampness-Heat RetentionIdentifying chemicals with potential therapy of HIV based on protein-protein and protein-chemical interaction networkAn attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challengeEukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-κB.Molecular mechanisms involved in HIV-1 Tat-mediated induction of IL-6 and IL-8 in astrocytes.The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses.Cancer-associated CD43 glycoforms as target of immunotherapy.Differential regulation of NF-κB-mediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins.Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA [corrected].Targeting of mTOR catalytic site inhibits multiple steps of the HIV-1 lifecycle and suppresses HIV-1 viremia in humanized mice.The HIV proteins Tat and Nef promote human bone marrow mesenchymal stem cell senescence and alter osteoblastic differentiation.Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic miceDesign and characterization of a peptide mimotope of the HIV-1 gp120 bridging sheetPsychostimulant Abuse and HIV Infection: cocaine, methamphetamine, and "bath salts" cathinone analogues.HIV-1 Tat protein enhances the intracellular growth of Leishmania amazonensis via the ds-RNA induced protein PKR.HIV-Tat regulates macrophage gene expression in the context of neuroAIDS.FKBP51 increases the tumour-promoter potential of TGF-beta.Electro-Magnetic Nano-Particle Bound Beclin1 siRNA Crosses the Blood-Brain Barrier to Attenuate the Inflammatory Effects of HIV-1 Infection in Vitro.Aberrant glycosylation as biomarker for cancer: focus on CD43.HIV-1 Tat Primes and Activates Microglial NLRP3 Inflammasome-Mediated Neuroinflammation.Small GTPase Rap1 regulates cell migration through regulation of small GTPase RhoA activity in response to transforming growth factor-β1.Functional roles of HIV-1 Tat protein in the nucleus.Measuring the Uptake and Transactivation Function of HIV-1 Tat Protein in a Trans-cellular Cocultivation Setup.TAT cell-penetrating peptide modulates inflammatory response and apoptosis in human lung epithelial cells.Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection.Primate Lentiviruses Modulate NF-κB Activity by Multiple Mechanisms to Fine-Tune Viral and Cellular Gene Expression.The HIV-1 Tat protein modulates CD4 expression in human T cells through the induction of miR-222.Synergy between enzastaurin doxorubicin in inducing melanoma apoptosis.MiR-34a is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFκB pathway.Importance of Autophagy in Mediating Human Immunodeficiency Virus (HIV) and Morphine-Induced Metabolic Dysfunction and Inflammation in Human Astrocytes.Stability of HIV-1 subtype B and C Tat is associated with variation in the carboxyl-terminal region.HIV-1 Rev downregulates Tat expression and viral replication via modulation of NAD(P)H:quinine oxidoreductase 1 (NQO1).Oxidative Stress Markers in Tuberculosis and HIV/TB Co-Infection.Changes in the cellular microRNA profile by the intracellular expression of HIV-1 Tat regulator: A potential mechanism for resistance to apoptosis and impaired proliferation in HIV-1 infected CD4+ T cells.Incorporating the type and direction information in predicting novel regulatory interactions between HIV-1 and human proteins using a biclustering approach.HIV-1 Tat protein induces DNA damage in human peripheral blood B-lymphocytes via mitochondrial ROS production.Are Evolution and the Intracellular Innate Immune System Key Determinants in HIV Transmission?Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents.DEAD-box helicase 27 promotes colorectal cancer growth and metastasis and predicts poor survival in CRC patients.
P2860
Q28082629-CD10D949-2889-45A0-8600-F2CBD82B2A37Q28394514-7FFADA13-82F2-498E-88DF-09CD2DE6112BQ28533728-DACA0109-1463-4561-BFB6-E6ABEC27B3BEQ33916162-913AB522-93B5-44CA-A6F3-CEC221411C66Q34776278-7423F0F8-8CBC-424A-8EBE-012F6634C4C3Q34998247-6EF558AF-2777-4973-B96F-0C5B844A5964Q35040673-DD4D9A5A-6F1A-4442-9AF7-2DA9644C57E6Q35072238-D61C2C49-53F0-4EC4-BF9D-0BEA42666613Q35549043-A996AB5D-6813-4D32-886D-8FFA4505F806Q35574768-06F818A9-4E57-4F7B-BB99-8E069BC21896Q35910232-124E0993-8D2F-472D-8C00-41BC73F416D2Q35935135-633A89E1-CACF-46D4-98CC-C8D2FE49A910Q36032171-B653831A-5217-48ED-89C0-3D8390D01F50Q36057328-3D4B9817-A9C7-4418-AB71-7747C54815EDQ36091506-9A879E0B-EEE1-491C-B000-0B8EE0F3DA2CQ36320721-94DF2E98-5BCD-42AA-8125-72A51125A3D0Q36412589-5BA96606-20A3-467B-A70F-3461B2E8B259Q37531822-8B8A2852-DAFF-4508-96B6-5FE282C1C583Q37590479-E5C06BA9-0473-49F0-A325-7E0BF39EF13FQ37618865-9AA08F70-894E-4ABC-8BF2-6C9860C19F98Q38375685-B294C531-5B3C-4E48-AA8A-08499C807684Q38451651-A5D0AE70-1A25-4BD0-8299-A0074D9B78F1Q38617624-239376A6-AC7D-4B98-A67D-C396789C55B7Q38808192-213B0512-A1B5-4956-9E15-ACC509565E9DQ38881895-C2BD6A43-0AB8-497B-B1CB-A91AD7DCAF78Q38885663-4B302A51-6B30-41E9-92E8-B71D8742457DQ38928538-80D852A4-3382-47B2-B8FF-FC7E94630206Q39005882-B972219F-604C-478F-95BC-E7B9547D1341Q39124162-62FDD445-85FB-4FE0-9003-82874164AF70Q39252620-B3333EF3-FF29-46C2-911E-CC2E74F4F10BQ40090533-AD40C8A9-CDC6-4D53-BA18-B148677B9D44Q40743714-09841E93-EE26-4C58-97AC-F989BB371028Q41172672-75EF4DE3-9B72-47F3-9DBD-BCE0A8338C56Q41926336-8F633E8A-8F52-4086-82E4-9B8DBA94D6EFQ41926635-6A5D75D9-525B-4B96-8967-04B2325CE4C9Q41951886-AD9AD9B1-510C-4686-B822-441B4D5C95E8Q46245165-97FDF1FB-2250-40FC-9784-7C3E168E1FC7Q47146547-81719634-AF74-4DC9-A534-7711B0D93BF8Q49925023-6517C8E8-B7EE-49F3-ABB7-71548AF86EA1Q52726771-38DD5AD1-EC0C-436E-A1E9-6B084C21345C
P2860
Human immunodeficiency virus-1 Tat activates NF-κB via physical interaction with IκB-α and p65.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Human immunodeficiency virus-1 ...... nteraction with IκB-α and p65.
@ast
Human immunodeficiency virus-1 ...... nteraction with IκB-α and p65.
@en
type
label
Human immunodeficiency virus-1 ...... nteraction with IκB-α and p65.
@ast
Human immunodeficiency virus-1 ...... nteraction with IκB-α and p65.
@en
prefLabel
Human immunodeficiency virus-1 ...... nteraction with IκB-α and p65.
@ast
Human immunodeficiency virus-1 ...... nteraction with IκB-α and p65.
@en
P2093
P2860
P356
P1476
Human immunodeficiency virus-1 ...... interaction with IκB-α and p65
@en
P2093
Annalisa Rossi
Annamaria De Laurentiis
Annarita Scialdone
Antonio Pisano
Cristina Falcone
Eleonora Vecchio
Francesca Fasanella Masci
Francesca Trimboli
Giuseppe Scala
Ileana Quinto
P2860
P304
P356
10.1093/NAR/GKR1224
P407
P577
2011-12-19T00:00:00Z